title: Survival of women with inflammatory breast cancer: a large population-based study.
abstract: BACKGROUND
  Our group has previously reported that women with inflammatory breast cancer (IBC) continue to have worse outcome compared with those with non-IBC. We undertook this population-based study to see if there have been improvements in survival among women with stage III IBC, over time.
  
  
  METHODS
  We searched the Surveillance, Epidemiology and End Results Registry to identify female patients diagnosed with stage III IBC between 1990 and 2010. Patients were divided into four groups according to year of diagnosis: 1990-1995, 1996-2000, 2001-2005, and 2006-2010. Breast cancer-specific survival (BCSS) was estimated using the Kaplan-Meier method and compared across groups using the log-rank test. Cox models were then fit to determine the association of year of diagnosis and BCSS after adjusting for patient and tumor characteristics.
  
  
  RESULTS
  A total of 7679 patients with IBC were identified of whom 1084 patients (14.1%) were diagnosed between 1990 and 1995, 1614 patients (21.0%) between 1996 and 2000, 2683 patients (34.9%) between 2001 and 2005, and 2298 patients (29.9%) between 2006 and 2010. The 2-year BCSS for the whole cohort was 71%. Two-year BCSS were 62%, 67%, 72%, and 76% for patients diagnosed between 1990-1995, 1996-2000, 2001-2005, and 2006-2010, respectively (P < 0.0001). In the multivariable analysis, increasing year of diagnosis (modeled as a continuous variable) was associated with decreasing risks of death from breast cancer (HR = 0.98, 95% confidence interval 0.97-0.99, P < 0.0001).
  
  
  CONCLUSIONS
  There has been a significant improvement in survival of patients diagnosed with IBC over a two-decade time span in this large population-based study. This suggests that therapeutic strategies researched and evolved in the context of non-IBC have also had a positive impact in women with IBC.
authors.affiliation: Department of Medical Oncology, Dubai Hospital, Dubai, UAE Shaheenah@post.harvard.edu.
authors.forename: S
authors.initials: S
authors.lastname: Dawood
authors.affiliation: Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, USA.
authors.forename: X
authors.initials: X
authors.lastname: Lei
authors.affiliation: Department of Medical Oncology, Singapore.
authors.forename: R
authors.initials: R
authors.lastname: Dent
authors.affiliation: Department of Breast Medical Oncology, Tata Memorial Centre, Mumbai, India.
authors.forename: S
authors.initials: S
authors.lastname: Gupta
authors.affiliation: Department of Breast Medical Oncology, Tata Memorial Centre, Mumbai, India.
authors.forename: B
authors.initials: B
authors.lastname: Sirohi
authors.affiliation: Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona, Spain.
authors.forename: J
authors.initials: J
authors.lastname: Cortes
authors.affiliation: Department of Medical Oncology, Thomas Jefferson University, Philadelphia.
authors.forename: M
authors.initials: M
authors.lastname: Cristofanilli
authors.affiliation: Departments of Radiation Oncology.
authors.forename: T
authors.initials: T
authors.lastname: Buchholz
authors.affiliation: Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA.
authors.forename: A M
authors.initials: AM
authors.lastname: Gonzalez-Angulo
mesh_terms: D000328:Adult; D000368:Aged; D005260:Female; D006801:Humans; D058922:Inflammatory Breast Neoplasms / Q000401:mortality*; D053208:Kaplan-Meier Estimate; D008875:Middle Aged; D016016:Proportional Hazards Models; D018426:SEER Program; D055815:Young Adult
keywords: inflammatory breast cancer; stage III; survival; time trends